These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3959024)

  • 1. Tranexamic acid derivatives with enhanced absorption.
    Svahn CM; Merenyi F; Karlson L; Widlund L; Grälls M
    J Med Chem; 1986 Apr; 29(4):448-53. PubMed ID: 3959024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The synthesis of 4'-(2-carboxyethyl)phenyl trans-4-aminomethyl cyclohexane carboxylate hydrochloride (cetraxate hydrochloride) by means of enzymatic debenzylation].
    Kuroda H; Miyadera A; Kaneuchi T; Imura A
    Yakugaku Zasshi; 1989 Mar; 109(3):157-62. PubMed ID: 2754616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absorption of tranexamic acid as a prodrug in healthy volunteers.
    Svahn CM; Schannong M; Stenberg U; Widlund L
    Arzneimittelforschung; 1988 May; 38(5):735-8. PubMed ID: 3415720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medicinal chemical studies on antiplasmin drugs. VIII. 4-Aminomethylcyclohexanecarboxylic acid derivatives having a carboxyl or carboxymethyl group at C2.
    Isoda S; Yamaguchi H
    Chem Pharm Bull (Tokyo); 1980 Aug; 28(8):2337-46. PubMed ID: 7428125
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pharmacokinetic and pharmacological studies on cetraxate, an anti-ulcer agent].
    Tanaka H; Naito S
    Nihon Yakurigaku Zasshi; 1985 May; 85(5):357-66. PubMed ID: 4029808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medicinal chemical studies on antiplasmin drugs. VII. Oxa analogs of 4-aminomethylcyclohexanecarboxylic acid.
    Isoda S; Yamaguchi H; Satoh Y; Hirata M
    Chem Pharm Bull (Tokyo); 1980 Aug; 28(8):2329-36. PubMed ID: 7428124
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacokinetics and bioavailability of tranexamic acid.
    Pilbrant A; Schannong M; Vessman J
    Eur J Clin Pharmacol; 1981; 20(1):65-72. PubMed ID: 7308275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Syntheses and inhibitory effects on gastric lesions of trans-guanidinomethylcyclohexane carboxylic acid arylamides.
    Ueda H; Momoi Y; Ikeda T; Kakegawa H; Miyataka H; Matsumoto H; Satoh T
    Chem Pharm Bull (Tokyo); 1993 Mar; 41(3):522-4. PubMed ID: 8477502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and absolute bioavailability of intramuscular tranexamic acid in man.
    Puigdellívol E; Carral ME; Moreno J; Plà-Delfina JM; Jané F
    Int J Clin Pharmacol Ther Toxicol; 1985 Jun; 23(6):298-301. PubMed ID: 4018929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Partial purification, and some properties and reactivities of cetraxate benzyl ester hydrochloride-hydrolyzing enzyme.
    Kuroda H; Miyadera A; Imura A; Suzuki A
    Chem Pharm Bull (Tokyo); 1989 Nov; 37(11):2929-32. PubMed ID: 2632040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of tranexamic acid on tumour blood flow.
    Sundbeck A; Alpsten M; Appelgren L; Karlsson L; Månsson LG; Peterson HI
    Anticancer Res; 1981; 1(3):141-8. PubMed ID: 7342852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasminogen-plasmin system IX. Specific binding of tranexamic acid to plasmin.
    Iwamoto M
    Thromb Diath Haemorrh; 1975 Jun; 33(3):573-85. PubMed ID: 125463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of tranexamic acid on gastric bleeding in rats.
    Berstad A; Almodovar K; Berstad K; Anderson W; Hirschowitz BI
    Scand J Gastroenterol; 1988 May; 23(4):402-6. PubMed ID: 3260041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Special considerations with regard to the dosage of tranexamic acid in patients with chronic renal diseases.
    Andersson L; Eriksson O; Hedlund PO; Kjellman H; Lindqvist B
    Urol Res; 1978; 6(2):83-8. PubMed ID: 664136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory effect of prolonged oral administration of cetraxate hydrochloride on experimentally-induced intestinal metaplasia in Wistar rats.
    Tatsuta M; Yamamura H; Iishi H; Taniguchi H
    Arzneimittelforschung; 1987 Sep; 37(9):1045-8. PubMed ID: 3435599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The preventative effect of the antifibrinolytic agents, epsilon-aminocaproic acid and tranexamic acid, on stress ulcer formation in rats.
    Kodama Y; Kumashiro R; Gain T; Matsumoto T
    Int Surg; 1983; 68(4):361-3. PubMed ID: 6668161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum and aqueous humour concentration of tranexamic acid after peroral administration.
    Bramsen T
    Acta Ophthalmol (Copenh); 1979 Jun; 57(3):455-60. PubMed ID: 474089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of tranexamic acid on tumour vascularization. An experimental microangiographic study.
    Sundbeck A; Myrhage R; Peterson HI
    Anticancer Res; 1981; 1(5):295-8. PubMed ID: 6179453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tranexamic acid and gastric fibrinolysis in the rat.
    Stenberg B; Risberg B; Peterson HI
    Thromb Haemost; 1980 Feb; 42(5):1425-8. PubMed ID: 7368148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of tranexamic acid on pulmonary tissue fibrinolysis in the rat.
    Risberg B
    Microvasc Res; 1976 May; 11(3):307-14. PubMed ID: 933860
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.